Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular Risk

• Main Authors: Trevor Simard (Author), Richard G. Jung (Author), Pietro Di Santo (Author), F. Daniel Ramirez (Author), Alisha Labinaz (Author), Chantal Gaudet (Author), Pouya Motazedian (Author), Simon Parlow (Author), Joanne Joseph (Author), Robert Moreland (Author), Jeffrey Marbach (Author), Paul Boland (Author), Steven Promislow (Author), Juan J. Russo (Author), Aun‐Yeong Chong (Author), Derek So (Author), Michael Froeschl (Author), Michel Le May (Author), Benjamin Hibbert (Author)
• Format: Book
• Published: Wiley, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Adenosine boasts promising preclinical and clinical data supporting a vital role in modulating vascular homeostasis. Its widespread use as a diagnostic and therapeutic agent have been limited by its short half‐life and complex biology, though adenosine‐modulators have shown promise in improving vasc...